P757: Long-term effectiveness and safety of adalimumab based on Crohn’s disease duration: Results from the PYRAMID registryECCO '18 Vienna
2018
P759: Ustekinumab as rescue treatment in therapy-refractory or -intolerant ulcerative colitisECCO '18 Vienna
2018
P760: Monitoring of laboratory parameters during thiopurine maintenance therapy in patients with inflammatory bowel disease: An unnecessary burden?ECCO '18 Vienna
2018
P761: IFX dose-escalation strategy based on a population PK model in IBD patients with secondary loss of responseECCO '18 Vienna
2018
P762: GO-CARE: A prospective multi-centre observational study of golimumab effectiveness and quality of life in a real-life UC patient population in ItalyECCO '18 Vienna
2018
P763: Quality of life in Paediatric inflammatory bowel disease Patient: How well do we understand patients?ECCO '18 Vienna
2018
P764: Drug level thresholds in patients with Crohn’s disease on dose-intensified anti-TNF therapy predict intestinal wall healing for infliximab but not adalimumabECCO '18 Vienna
2018
P768: Extended enoxaparin venous thromboembolism prophylaxis after surgery for inflammatory bowel disease: A cost-based decision-analysisECCO '18 Vienna
2018
P769: Hypophosphatemia in patients with inflammatory bowel disease after intravenous iron infusion: One centre prospective studyECCO '18 Vienna
2018
P770: Can we predict mucosal inflammation in children with inflammatory bowel disease without colonoscopy?ECCO '18 Vienna
2018
P771: Diagnostic performance of low haemoglobin density (LHD%) for detecting iron deficiency in patients with inflammatory bowel diseaseECCO '18 Vienna
2018
P772: Factors influencing adherence to oral 5-aminosalicylic acid in patients with ulcerative colitisECCO '18 Vienna
2018
P773: Rescue treatment with tacrolimus in patients with severe inflammatory bowel disease (IBD) without response to intensification of biological therapyECCO '18 Vienna
2018
P774: Comparison of disease burden of ulcerative colitis patients treated with biologics/biosimilars in remission and not in remission across the EU5ECCO '18 Vienna
2018